Sunday, December 5

Despair in Latin American countries due to Sputnik V delivery delays


Millions of people from Latin America to the Middle East eagerly await the first or second dose of Sputnik V.

The Russian vaccine against covid-19 was presented in the middle of the pandemic as the most viable option for developing countries, since world powers had monopolized the other vaccines.

However, Russia has not been able to meet estimated deliveries and this has led to significant delays in vaccination campaigns in some countries.

For example, Venezuela requested about 10 million doses of Sputnik V in December 2020 but to date it has only received just over 3 million.

In Caracas, Esperita García Pérez, 88, received her first dose last May. But the months pass and the second dose does not arrive. A month ago he was infected with covid, after surviving he waits with faith to receive the complete guideline.

“I was anxious for many, many months waiting [la segunda dosis de la vacuna Sputnik V]. They said I was going to come, then they said no, then they said I was going to have to wait, then I was not going to have to wait, and then I said to myself, ‘Oh my God, if people can’t get the second dose, why? what did they get the first dose if they can’t get the second? ‘”

Unlike other covid-19 vaccines, the first and second injections of the Russian drug are different and not interchangeable.

Compliance with delivery times has allegedly been affected by production and manufacturing difficulties. Experts have pointed out Russia’s limited production capacity, as well as the complex process of making the second dose.

“The second component [de la vacuna Sputnik V], say, it is produced with difficulty [que el primero]; as these are living cells that produce viruses, this definition fully applies to this. How much slower it grows, what is the reason: it is a mystery to me, I have not seen answers to these questions anywhere. The fact is that the second component of the Sputnik V vaccine is more difficult to produce than the first, “explains Ilya Yasny, head of scientific research at the Russian investment fund Inbio Ventures.

But Russia says the problem has been solved, confirms Kirill Dmitriev, CEO of Russia’s Direct Investment Fund.

“All of these issues have been fully resolved, so we will not have any further delays with the second dose in third countries. All vaccine manufacturers are known to have had some delays in deliveries at some point, so there is no manufacturer of vaccines. vaccines in the world that have not had such problems. “

One consultancy estimates that Russia has only exported 4.8% of the nearly 1 billion promised doses. Sputnik delays in countries like Argentina and Venezuela have caused some people to receive a different vaccine for their second dose, although scientists are still studying the effects of this combination.


feedproxy.google.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Share